The National Cancer Institute (NCI) has made a significant investment in the Genomic Data Commons (GDC) which already possesses robust analytical and visualization tools. There is a sizeable amount of genomic and phenotypic information relevant to pediatric malignancies currently residing in the database of Genotypes and Phenotypes (dbGaP). The NCI could play a role in ensuring that data in dbGaP is made available through the GDC. Subsequently, data analysis would not be limited to researchers who possess and maintain in-house analytical and visualization tools. NCI's efforts to expedite the process of requesting access to dbGaP data would incentivize investigators' use of the GDC and in turn foster research.